<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-HU2V917N</identifier><date>2010</date><creator>Jazbec, Janez</creator><creator>Prelog, Tomaž</creator><relation>documents/doc/H/URN_NBN_SI_doc-HU2V917N_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HU2V917N_001.txt</relation><format format_type="volume">17</format><format format_type="issue">3</format><format format_type="type">article</format><format format_type="extent">str. 150-155</format><identifier identifier_type="ISSN">1318-4423</identifier><identifier identifier_type="COBISSID">257783808</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HU2V917N</identifier><language>slv</language><publisher publisher_location="Ljubljana">Združenje pediatrov Slovenije</publisher><publisher publisher_location="Ljubljana">Združenje specialistov šolske in visokošolske medicine Slovenije</publisher><source>Slovenska pediatrija</source><rights>BY-NC</rights><subject language_type_id="slv">akutna levkemija</subject><subject language_type_id="slv">levkemija</subject><subject language_type_id="slv">metodologija</subject><subject language_type_id="slv">minimalna rezidualna bolezen</subject><subject language_type_id="slv">otroci</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">stranski učinki</subject><subject language_type_id="slv">zdravljenje</subject><title>Pomen določanja minimalne rezidualne bolezni pri zdravljenju akutne limfoblastne levkemije v pediatriji</title><title>Importance of the determination of minimum residual disease in treatment of acute lymphoblastic leukaemia in paediatrics</title></Record>